thought leadership

The Demand for Nanoparticles in Drug Formulation is Rising

Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect and deliver medicines and vaccines where they need to go in the body, has been increasing since 1989.

Collaborating with an experienced partner, such as a CDMO, could prove to be invaluable in developing nano-based systems. 

Read more about the benefits and challenges of nanoparticle production. 

Download Article

 

Focus on Fill and Finish

Kelly Christiansen, vice president & general manager of Emergent CDMO's Rockville drug product manufacturing facility recently...

READ MORE
Rockville, MD

An Inside Look at Drug Product Manufacturing

Emergent's drug product manufacturing facility in Rockville, MD is home to the groninger® INTEGRA, a state-of-the-art high speed...

READ MORE

Factoring Stability in the Biologic Drug Mix

Jee Look, senior director of drug product development for Emergent BioSolutions recently contributed to an article in ...

READ MORE